PT Series

PT-141

Bremelanotide

Purity

≥98%

Form

Lyophilised Powder

Quantity

10mg / vial

€79.00

Third-Party Tested

CoA Available

EU Shipping

Storage: Store at −20°C. Stable for 24 months lyophilised.

Research Overview

PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. Unlike PDE5 inhibitors, PT-141 acts centrally via MC3R and MC4R receptors in the hypothalamus, activating dopaminergic pathways. Research documents its effects on arousal and motivational circuitry independent of the vascular system.

Documented Benefits

Central MC3R/MC4R receptor agonism
Dopaminergic pathway activation
Non-vascular mechanism of action
Well-characterised pharmacokinetic profile

Related Compounds

For research purposes only. Not intended for human consumption. Certificate of Analysis available upon request.